Invivo Therapeutics Holdings Corp (NASDAQ: NVIV) Announces FDA Approval of Its Complete HDE Submission

Invivo Therapeutics Holdings Corp (NASDAQ: NVIV) is a clinical-stage and research biotech and biomaterials company that focuses on spinal cord injury treatments. The company recently announced that it got FDA acceptance for its pre-clinical module. This is one of the modules needed for InVivo’s HDE (humanitarian device exemption) application. The module’s […]